Mission

ICER's mission is to lead innovation in comparative effectiveness research through methods that integrate considerations of clinical benefit and economic value.  Through a unique collaboration with patients, clinicians, manufacturers, insurers and other healthcare stakeholders, ICER develops tools to support patient decisions and medical policy that share the goal of achieving maximum value for every healthcare dollar.

TwitterLinkedinFacebookFeed
ICER's COO Presents to New Hampshire Prostate Cancer Coalition

ICER's COO, Sarah Emond, presented the "Your Options for Low-Risk Prostate Cancer" web-based decision aid to the members of the New Hampshire Prostate Cancer Coalition on October 22, 2011.